Genomic Hippo Pathway Alterations and Persistent YAP/TAZ Activation: New Hallmarks in Head and Neck Cancer
Open Access
Abstract
Head and neck squamous cell carcinoma (HNSCC) represents a highly prevalent and deadly malignancy worldwide. The prognosis for locoregionally advanced HNSCC has not appreciably improved over the past 30 years despite advances in surgical, radiation, and targeted therapies and less than 20% of HNSCC patients respond to recently approved immune checkpoint inhibitors. The Hippo signaling pathway, originally discovered as a mechanism regulating tissue growth and organ size, transduces intracellular and extracellular signals to regulate the transcriptional co-activators YAP and TAZ. Alterations in the Hippo pathway resulting in persistent YAP and TAZ activation have emerged as major oncogenic drivers. Our analysis of the human HNSCC oncogenome revealed multiple genomic alterations impairing Hippo signaling and activating YAP and TAZ, which in turn contribute to HNSCC development. This includes mutations and deletions of the FAT1 gene (29%) and amplification of the WWTR1 (encoding TAZ, 14%) and YAP1 genes (8%), together representing one of the most genetically altered signaling mechanisms in this malignancy. Here, we discuss key elements of the mammalian Hippo pathway, detail mechanisms by which perturbations in Hippo signaling promote HNSCC initiation and progression and outline emerging strategies to target Hippo signaling vulnerabilities as part of novel multimodal precision therapies for HNSCC.Keywords
Funding Information
- National Institutes of Health (T32 DC000028, T32 AI007036, U01 DE028227, R01 DE026870, R25CA221779, R01 DE026644, R01 CA247551, R01 DE030497)
This publication has 139 references indexed in Scilit:
- Crystal structure of a Tankyrase-Axin complex and its implications for Axin turnover and Tankyrase substrate recruitmentProceedings of the National Academy of Sciences, 2012
- Mst1 and Mst2 protein kinases restrain intestinal stem cell proliferation and colonic tumorigenesis by inhibition of Yes-associated protein (Yap) overabundanceProceedings of the National Academy of Sciences, 2011
- E-cadherin mediates contact inhibition of proliferation through Hippo signaling-pathway componentsProceedings of the National Academy of Sciences, 2011
- Yap1 Acts Downstream of α-Catenin to Control Epidermal ProliferationCell, 2011
- YAP dysregulation by phosphorylation or ΔNp63-mediated gene repression promotes proliferation, survival and migration in head and neck cancer subsetsOncogene, 2010
- The Merlin/NF2 Tumor Suppressor Functions through the YAP Oncoprotein to Regulate Tissue Homeostasis in MammalsDevelopmental Cell, 2010
- Kibra Functions as a Tumor Suppressor Protein that Regulates Hippo Signaling in Conjunction with Merlin and ExpandedDevelopmental Cell, 2010
- Tankyrase inhibition stabilizes axin and antagonizes Wnt signallingNature, 2009
- A crucial role of WW45 in developing epithelial tissues in the mouseThe EMBO Journal, 2008
- Elucidation of a Universal Size-Control Mechanism in Drosophila and MammalsCell, 2007